How did we get here? Short history of COVID-19 and other coronavirus-related epidemics
- PMID: 32445249
- PMCID: PMC7283747
- DOI: 10.1002/hed.26275
How did we get here? Short history of COVID-19 and other coronavirus-related epidemics
Abstract
The COVID-19 epidemic was not the first coronavirus epidemic of this century and represents one of the increasing number of zoonoses from wildlife to impact global health. SARS CoV-2, the virus causing the COVID-19 epidemic is distinct from, but closely resembles SARS CoV-1, which was responsible for the severe acute respiratory syndrome (SARS) outbreak in 2002. SARS CoV-1 and 2 share almost 80% of genetic sequences and use the same host cell receptor to initiate viral infection. However, SARS predominantly affected individuals in close contact with infected animals and health care workers. In contrast, CoV-2 exhibits robust person to person spread, most likely by means of asymptomatic carriers, which has resulted in greater spread of disease, overall morbidity and mortality, despite its lesser virulence. We review recent coronavirus-related epidemics and distinguish clinical and molecular features of CoV-2, the causative agent for COVID-19, and review the current status of vaccine trials.
Keywords: COVID-19; coronavirus; head and neck surgery; otolaryngology; review.
© 2020 Wiley Periodicals, Inc.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.Vaccine. 2020 Jun 26;38(31):4783-4791. doi: 10.1016/j.vaccine.2020.05.064. Epub 2020 May 25. Vaccine. 2020. PMID: 32507409 Free PMC article.
-
Coronavirus vaccines get a biotech boost.Nature. 2020 Jul;583(7817):647-649. doi: 10.1038/d41586-020-02154-2. Nature. 2020. PMID: 32694847 No abstract available.
-
Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.J Virol. 2020 Oct 14;94(21):e01062-20. doi: 10.1128/JVI.01062-20. Print 2020 Oct 14. J Virol. 2020. PMID: 32788194 Free PMC article.
-
Variations in SARS-CoV-2 Spike Protein Cell Epitopes and Glycosylation Profiles During Global Transmission Course of COVID-19.Front Immunol. 2020 Sep 4;11:565278. doi: 10.3389/fimmu.2020.565278. eCollection 2020. Front Immunol. 2020. PMID: 33013929 Free PMC article.
-
Emergence of a Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options.J Clin Microbiol. 2020 Apr 23;58(5):e00187-20. doi: 10.1128/JCM.00187-20. Print 2020 Apr 23. J Clin Microbiol. 2020. PMID: 32161092 Free PMC article. Review.
Cited by
-
The clinical consequences of the COVID-19 lockdown: A report from an Italian referral ENT department.Laryngoscope Investig Otolaryngol. 2020 Aug 26;5(5):824-831. doi: 10.1002/lio2.446. eCollection 2020 Oct. Laryngoscope Investig Otolaryngol. 2020. PMID: 32904910 Free PMC article.
-
DElayed COloRectal cancer care during COVID-19 Pandemic (DECOR-19): Global perspective from an international survey.Surgery. 2021 Apr;169(4):796-807. doi: 10.1016/j.surg.2020.11.008. Epub 2020 Nov 17. Surgery. 2021. PMID: 33353731 Free PMC article.
-
Acute complete splenic infarction secondary to COVID-19 infection.Radiol Case Rep. 2022 Mar 2;17(5):1402-1406. doi: 10.1016/j.radcr.2022.02.008. eCollection 2022 May. Radiol Case Rep. 2022. PMID: 35242265 Free PMC article.
-
The Frailty of the Invincible.Transl Med UniSa. 2020 Oct 31;23:1-15. doi: 10.37825/2239-9747.1000. eCollection 2020 Oct. Transl Med UniSa. 2020. PMID: 33457314 Free PMC article.
-
Increasing COVID-19 vaccine acceptance among the general population while maintaining autonomy.Hum Vaccin Immunother. 2021 Dec 2;17(12):5139-5141. doi: 10.1080/21645515.2021.1922265. Hum Vaccin Immunother. 2021. PMID: 35213945 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous